697 related articles for article (PubMed ID: 30297972)
1. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
[TBL] [Abstract][Full Text] [Related]
2. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
[TBL] [Abstract][Full Text] [Related]
3. Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy.
Lakdawala NK; Olivotto I; Day SM; Han L; Ashley EA; Michels M; Ingles J; Semsarian C; Jacoby D; Jefferies JL; Colan SD; Pereira AC; Rossano JW; Wittekind S; Ware JS; Saberi S; Helms AS; Cirino AL; Leinwand LA; Seidman CE; Ho CY
Circ Genom Precis Med; 2021 Feb; 14(1):e003062. PubMed ID: 33284039
[TBL] [Abstract][Full Text] [Related]
4. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
[TBL] [Abstract][Full Text] [Related]
5. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.
Marstrand P; Han L; Day SM; Olivotto I; Ashley EA; Michels M; Pereira AC; Wittekind SG; Helms A; Saberi S; Jacoby D; Ware JS; Colan SD; Semsarian C; Ingles J; Lakdawala NK; Ho CY;
Circulation; 2020 Apr; 141(17):1371-1383. PubMed ID: 32228044
[TBL] [Abstract][Full Text] [Related]
7. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
Bonaventura J; Rowin EJ; Chan RH; Chin MT; Puchnerova V; Polakova E; Macek M; Votypka P; Batorsky R; Perera G; Koethe B; Veselka J; Maron BJ; Maron MS
J Am Heart Assoc; 2024 May; 13(10):e033565. PubMed ID: 38757491
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Clinical Characteristics, and Long-term Outcome of the Dilated Phase of Hypertrophic Cardiomyopathy.
Aizawa Y; Tanimoto Y; Hirata Y; Fujisawa T; Fukuoka R; Nakajima K; Katsumata Y; Nishiyama T; Kimura T; Yuasa S; Kohno T; Kohsaka S; Murata M; Maekawa Y; Furukawa Y; Takatsuki S; Fukuda K
Keio J Med; 2019 Dec; 68(4):87-94. PubMed ID: 30606897
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.
Jääskeläinen P; Vangipurapu J; Raivo J; Kuulasmaa T; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Vanninen S; Hämäläinen L; Melin J; Kokkonen J; Nieminen MS; ; Laakso M; Kuusisto J
ESC Heart Fail; 2019 Apr; 6(2):436-445. PubMed ID: 30775854
[TBL] [Abstract][Full Text] [Related]
11. Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
Abou Alaiwi S; Roston TM; Marstrand P; Claggett BL; Parikh VN; Helms AS; Ingles J; Lampert R; Lakdawala NK; Michels M; Owens AT; Rossano JW; Saberi S; Abrams DJ; Ashley EA; Semsarian C; Stendahl JC; Ware JS; Miller E; Ryan TD; Russell MW; Day SM; Olivotto I; Vissing CR; Ho CY
Circulation; 2023 Aug; 148(5):394-404. PubMed ID: 37226762
[TBL] [Abstract][Full Text] [Related]
12. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
[TBL] [Abstract][Full Text] [Related]
13. Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy.
Jang JH; Shin SH; Beak YS; Ko KY; Kwon SW; Park SD; Woo SI; Kim DH; Kwan J
Heart Vessels; 2020 Feb; 35(2):214-222. PubMed ID: 31482215
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic Cardiomyopathy: Challenging the Status Quo?
Younger J; Lo A; McCormack L; McGaughran J; Prasad S; Atherton JJ
Heart Lung Circ; 2020 Apr; 29(4):556-565. PubMed ID: 31982299
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
Marston NA; Han L; Olivotto I; Day SM; Ashley EA; Michels M; Pereira AC; Ingles J; Semsarian C; Jacoby D; Colan SD; Rossano JW; Wittekind SG; Ware JS; Saberi S; Helms AS; Ho CY
Eur Heart J; 2021 May; 42(20):1988-1996. PubMed ID: 33769460
[TBL] [Abstract][Full Text] [Related]
16. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy?
Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D
Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967
[TBL] [Abstract][Full Text] [Related]
17. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargement.
Limongelli G; Masarone D; Frisso G; Iacomino M; Ferrara I; Rea A; Gravino R; Bossone E; Salvatore F; Calabro R; Elliott P; Pacileo G
J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):249-254. PubMed ID: 26808413
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy.
Hamada T; Kubo T; Kitaoka H; Hirota T; Hoshikawa E; Hayato K; Shimizu Y; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Takata J; Doi YL
Clin Cardiol; 2010 Jul; 33(7):E24-8. PubMed ID: 20641106
[TBL] [Abstract][Full Text] [Related]
20. Left atrial dysfunction as marker of poor outcome in patients with hypertrophic cardiomyopathy.
Essayagh B; Resseguier N; Michel N; Casalta AC; Renard S; Donghi V; Carbone A; Piazzai C; Ambrosi P; Levy F; Martel H; Gérard H; Avierinos JF; N'Guyen K; Habib G
Arch Cardiovasc Dis; 2021 Feb; 114(2):96-104. PubMed ID: 33039326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
